Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
94.64
+4.68 (5.20%)
At close: May 12, 2025, 4:00 PM
94.64
0.00 (0.00%)
After-hours: May 12, 2025, 7:00 PM EDT
Glaukos Employees
Glaukos had 995 employees as of December 31, 2024. The number of employees increased by 88 or 9.70% compared to the previous year.
Employees
995
Change (1Y)
88
Growth (1Y)
9.70%
Revenue / Employee
$406,556
Profits / Employee
-$124,302
Market Cap
5.41B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GKOS News
- 11 days ago - Glaukos Corporation (GKOS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Glaukos Announces First Quarter 2025 Financial Results - Business Wire
- 13 days ago - Baron Health Care Fund Q1 2025 Top Contributors And Detractors - Seeking Alpha
- 19 days ago - Glaukos to Present Multiple Scientific Abstracts at the 2025 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting - Business Wire
- 26 days ago - Glaukos Announces the Release of its 2024 Sustainability Report - Business Wire
- 4 weeks ago - Glaukos to Release First Quarter 2025 Financial Results after Market Close on April 30 - Business Wire
- 2 months ago - RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution - Business Wire
- 2 months ago - FDA Sets Decision Date For Glaukos' Keratoconus Treatment Without The Need Of Surgery - Benzinga